Can HIV-1 superinfection compromise antiretroviral therapy?

AIDS. 2004 Jan 2;18(1):132-4. doi: 10.1097/00002030-200401020-00019.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Anti-Retroviral Agents / adverse effects*
  • Drug Resistance, Viral
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Molecular Sequence Data
  • Superinfection / immunology*

Substances

  • Anti-Retroviral Agents

Associated data

  • GENBANK/AY427722
  • GENBANK/AY427723
  • GENBANK/AY427724
  • GENBANK/AY427725
  • GENBANK/AY427726
  • GENBANK/AY427727
  • GENBANK/AY427728
  • GENBANK/AY427729
  • GENBANK/AY427730
  • GENBANK/AY427731
  • GENBANK/AY427732
  • GENBANK/AY427733
  • GENBANK/AY427734
  • GENBANK/AY427735
  • GENBANK/AY427736
  • GENBANK/AY427737
  • GENBANK/AY427738
  • GENBANK/AY427739
  • GENBANK/AY427740
  • GENBANK/AY427741
  • GENBANK/AY427742
  • GENBANK/AY427743
  • GENBANK/AY427744
  • GENBANK/AY427745
  • GENBANK/AY427746
  • GENBANK/AY427747
  • GENBANK/AY427748
  • GENBANK/AY427749
  • GENBANK/AY427750
  • GENBANK/AY427751